alexa Guangfu Li | Medical University of South Carolina
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Guangfu Li

Assistant Professor
Department of Surgery
Medical University of South Carolina
USA
 
Biography

Dr. Guangfu Li is Assistant Professor, Department of Surgery, Medical University of South Carolina, USA. He had developed and produced some engineered products including recombinant interferon-a (IFN-a), recombinant human parathyroid hormone (PTH), bispecific engineering antibody of anti-RBC and anti-HFRSV, and new type of recombinant vaccine adjuvant CpG. Using cell or animal systems. Dr. Guangfu Li worked with Dr. Kevin F. Staveley-O’Carroll for dissecting tumor-induced immunotolerance in hepatocellular cancer and developing innovative therapeutic strategies. Using the established orthotopic murine model, they found that sunitinib, a FDA-approved chemotherapy agent, prevents tumor-induced immunotolerance through modulating tumor-induced tolerant environment, and the combination of sunitinib with adoptive transfer of tumor antigen-specific T-cells completely eradicates the established tumors. Dr. Guangfu Li research interests include Translational cancer research, Cancer Immunotherapy, Cancer chemo-immunotherapy, DC-based cancer immunotherapy, iPSC-based cancer immunotherapy, STAT3 signaling and function, Macrophage and cancer.

Research Interest

Translational cancer research, Cancer Immunotherapy, Cancer chemo-immunotherapy, DC-based cancer immunotherapy, iPSC-based cancer immunotherapy, STAT3 signaling and function, Macrophage and cancer.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords